| Date Filed | Type | Description |
| 03/16/2023 |
4
| Erlander Mark (CEO) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Granted 482,064 options
@ $1.72, valued at
$829.2k
|
|
| 11/29/2022 |
4
| Erlander Mark (CEO) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Bought 10,000 shares
@ $1.43, valued at
$14.3k
|
|
| 03/10/2022 |
4
| Erlander Mark (CEO) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Granted 370,128 options
@ $2.5, valued at
$925.3k
|
|
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2020 |
4
| Erlander Mark (CEO) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Granted 221,241 options
@ $2.6, valued at
$575.2k
|
|
| 05/18/2020 |
4
| Erlander Mark (CEO) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Bought 6,993 shares
@ $1.43, valued at
$10k
|
|
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2019 |
4
| Erlander Mark (Chief Scientific Officer) has filed a Form 4 on Trovagene, Inc.|
Txns:
| Paid exercise price by delivering 461 shares
@ $0
Exercised 1,250 restricted stock units
@ $0 |
|
| 06/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/03/2019 |
4
| Erlander Mark (Chief Scientific Officer) has filed a Form 4 on Trovagene, Inc.|
Txns:
| Paid exercise price by delivering 459 shares
@ $0
Exercised 1,250 restricted stock units
@ $0 |
|
| 01/04/2019 |
4
| Erlander Mark (Chief Scientific Officer) has filed a Form 4 on Trovagene, Inc.|
Txns:
| Paid exercise price by delivering 698 shares
@ $0
Exercised 1,563 restricted stock units
@ $0 |
|
| 01/04/2019 |
4
| Erlander Mark (Chief Scientific Officer) has filed a Form 4 on Trovagene, Inc.|
Txns:
| Paid exercise price by delivering 3,035 shares
@ $0
Exercised 7,500 restricted stock units
@ $0 |
|
| 10/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2018 |
4
| Erlander Mark (Chief Scientific Officer) has filed a Form 4 on Trovagene, Inc.|
Txns:
| Granted 45,000 restricted stock units
@ $0 |
|
| 02/01/2018 |
4
| Erlander Mark (Chief Scientific Officer) has filed a Form 4 on Trovagene, Inc.|
Txns:
| Paid exercise price by delivering 42,930 shares
@ $0
Exercised 90,000 restricted stock units
@ $0 |
|
| 01/25/2018 |
4
| Erlander Mark (Chief Scientific Officer) has filed a Form 4 on Trovagene, Inc.|
Txns:
| Granted 672,189 options
@ $0.3, valued at
$201.7k
|
|
| 01/04/2018 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 01/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/15/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/04/2016 |
4
| Erlander Mark (Chief Scientific Officer) has filed a Form 4 on Trovagene, Inc.|
Txns:
| Granted 50,000 restricted stock units
@ $0 |
|